Literature DB >> 15516730

Essential oils from sweet basil (Ocimum basilicum) as novel enhancers to accelerate transdermal drug delivery.

Jia-You Fang1, Yann-Lii Leu, Tsong-Long Hwang, Hsiao-Chin Cheng.   

Abstract

The purpose of this study was to evaluate the essential oils from sweet basil (Ocimum basilicum, OB) as skin permeation enhancers to promote the percutaneous absorption of drugs. The in vitro and in vivo irritancy of the essential oils was also examined. Terpenes with various carbon numbers (mono-, sesqui-, di-, and tri-) were identified in both the lower-polarity fraction (OB-1) and higher-polarity fraction (OB-2). In vitro skin permeation and deposition of indomethacin were significantly enhanced after treatment with OB essential oils. The enhancing effect of OB-1 was greater than that of OB-2 in the in vitro permeation and in vivo cutaneous microdialysis analyses as well as in the plasma concentration of indomethacin. On the other hand, the in vivo study showed that OB-2 had a greater ability to retain the drug within the skin than did OB-1. Enhancement of the skin permeation of drugs by OB essential oils might be mainly due to improvement in the partitioning of the drugs to the stratum corneum. Both in vitro cell cultures (keratinocytes and skin fibroblasts) and in vivo transepidermal water loss showed no or only negligible irritation to skin by OB essential oils.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15516730     DOI: 10.1248/bpb.27.1819

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Effects of chemical enhancers on human epidermal membrane: Structure-enhancement relationship based on maximum enhancement (E(max)).

Authors:  Sarah A Ibrahim; S Kevin Li
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

2.  Lignans Isolated From Flower Buds of Magnolia fargesii Attenuate Airway Inflammation Induced by Cigarette Smoke in vitro and in vivo.

Authors:  Su-Ui Lee; Hyung Won Ryu; Seoghyun Lee; In-Sik Shin; Ji-Hee Choi; Jae-Won Lee; Jinhyuk Lee; Mun Ock Kim; Hyun-Jun Lee; Kyung-Seop Ahn; Sung-Tae Hong; Sei-Ryang Oh
Journal:  Front Pharmacol       Date:  2018-09-07       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.